Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Midroc New Technology is a Swedish venture capital firm, part of the Granitor group, that invests in early-stage pioneering technology companies. Their focus areas include cleantech, sustainable energy, and biomedicine, primarily in Sweden and Europe. They provide capital and strategic support to their portfolio companies rather than developing technologies themselves.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Midroc New Technology.